Arboreal Raises INR 230 Crore in Series A Round

Arboreal Bio innovations, a specialty food and nutraceutical ingredients tech company, has raised INR 230 crore in a Series A funding round co-led by EAAA, the alternatives arm of Edelweiss, and Omnivore. Existing investor Rainmatter by Zerodha also participated in the round. 

The company said the funding is among the largest Series A raises in India’s specialty food ingredients sector. The capital will be used to expand manufacturing capacity, strengthen research and development (R&D) capabilities, and accelerate the commercialization of its next-generation functional ingredients.

Arboreal develops specialty ingredients for the food, beverage and nutraceutical industries. Its technology platform integrates ingredient engineering, process R&D, formulation science and precision manufacturing to develop products tailored to the nutritional, functional and sensory requirements of Indian consumers and brands.

The company has commercialized proprietary ingredients across categories including next-generation proteins, cocoa-based ingredients, natural zero-calorie sweeteners and functional fibres. 

The company stated, their ingredient solutions supported more than 300 product launches across over 1,100 consumer brands and nutraceutical manufacturers during the past 18 months. 

Swati Pandey, Co-Founder and CEO, Arboreal Bioinnovations, said: “This fundraise is a strong validation of the direction we are taking as a company. It gives us the fuel to accelerate our mission of building clean, science-led solutions that address some of the world’s most pressing nutritional and food challenges, with innovation originating in India and reaching consumers globally.”

Manish Chauhan, Co-Founder and COO, Arboreal Bioinnovations, added: “This fundraise marks an important milestone in Arboreal’s journey from building IP-led ingredient technologies to enabling big shifts across categories through ingredient-first innovation. It gives us the ability to invest more deeply in science, manufacturing, talent and long-term innovation while building a platform capable of creating differentiated ingredients for food and nutraceutical brands.”

Commenting on the investment, Ashish Agarwal, Managing Director, Private Equity, EAAA Alternatives, said: “The investment in Arboreal reflects the core philosophy of our strategy of backing businesses with the potential to emerge as category leaders. We look forward to working with the founders as they continue to build leadership in R&D-led nutraceutical ingredients.”